Page 4 - Lee Ping Ing News Today

The locally developed Medigen COVID-19 vaccine has successfully completed a phase 3 clinical trial in Paraguay and received emergency use authorization (EUA) from the South American nation. The Taiwanese vaccine manufactured by Medigen Vaccine Biologics Corp (高端疫苗) was hailed by Taiwanese experts as an important milestone for domestically produced vaccines. Medigen’s vaccine has been gaining recognition from international institutions. It has been included in the WHO’s Solidarity Tri...

GLOBAL APPROVAL: Medigen is now waiting for the results of the WHO’s clinical trial evaluating the effectiveness of vaccines from around the worldBy Chiu Chih-jou and Liu Tzu-hsuan / Staff reporter, with staff writer

Lee Ping-ing (李秉穎), convener of the Ministry of Health and Welfare’s Advisory Committee on Immunization Practices (ACIP), yesterday explained the importance of receiving an additional or booster dose of a COVID-19 vaccine and urged people to get vaccinated as soon as possible, while the Central Epidemic Command Center (CECC) announced the arrival of a shipment of the AstraZeneca vaccine later yesterday. The CECC on Monday announced the ACIP’s latest recommendations for COVID-19 vaccina...

Increasing interval between shots to 6-14 weeks reduces chances of myocarditis without affecting immunity | 2021-11-30 19:34:00

Medigen vaccine data good but questions remain: Experts 06/11/2021 05:34 PM CNA file photo Taipei, June 11 (CNA) The Phase 2 clinical trial results of a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. generated good data, experts have said, but they cautioned there was still no way to know how effectively it will protect people against getting the disease. "Data looks quite good," Academia Sinica academician Michael M.C. Lai (賴明詔), a reputed virologist and coron...

Taipei, June 11 (CNA) Lee Chin-yun (李慶雲), a pediatrician and pioneer in vaccine development in Taiwan, died Friday at the age of 94, the Infectious Diseases Society of Taiwan said the same day.

Taipei, June 2 (CNA) Taiwan has recorded the first case of blood clotting linked to the AstraZeneca COVID-19 vaccination, the Central Epidemic Command Center (CECC) said Wednesday, but it did not recommend any changes in current vaccine procedures because of the problem.

Vaccine-related clotting reported ‘RARE’: A man in his 30s sought treatment for a headache and abdominal pain a week after receiving a dose of the AstraZeneca jab, and was found to have blood clotting By Lee I-chia / Staff reporter The Central Epidemic Command Center (CECC) yesterday reported the nation’s first case of thrombosis with thrombocytopenia syndrome (TTS) in a patient who had received a dose of the AstraZeneca COVID-19 vaccine. The ...

The next two weeks are critical for containing the COVID-19 outbreak, which hinges on the cooperation of confirmed cases and the public, infectious-disease experts said on Saturday. After a sharp spike in cases, the Central Epidemic Command Center on Saturday raised the pandemic alert for Taipei and New Taipei City to level 3 until May 28. While serious, Taiwan would make it through if the outbreak is contained over the next two weeks, said Chen Yee-chun (陳宜君), director of National Taiwan ...

Universal testing still unnecessary in Taiwan: CECC officials 05/12/2021 05:19 PM CNA file photo Taipei, May 12 (CNA) Officials from the Central Epidemic Command Center (CECC) indicated Wednesday that Taiwan will not carry out universal testing for COVID-19, even though the coronavirus disease has spread to local communities, saying such an approach was "useless" and would only make matters worse. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the CECC, told reporters bef...